ArticleJournal of family medicine and primary care2022
Sputum antibiogram in acute exacerbation of chronic obstructive pulmonary disease.
Article in Journal of family medicine and primary care, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Bacterial infections are the most common reason for acute exacerbation of chronic obstructive pulmonary disease (AECOPD). This can range from self-limited disease to respiratory failure requiring mechanical ventilation and is associated with increased mortality and morbidity in survivors. Aim: To ascertain common antibiotics effective in AECOPD using sputum bacterial culture and antibiotic susceptibility testing. Materials and Methods: In the present cross-sectional observational study, we analysed the sputum antibiogram in 237 patients who had not received antibiotics in the past 48 hours. Statistical analysis was performed, and the χ Results: Of 237 sputum samples, 77.2% were mucoid in nature, followed by purulent and mucopurulent sputum in 16.9% and 5.9% of cases, respectively. In the purulent/mucopurulent samples, 85.2% showed positive growth on culture compared to 35% of mucoid samples. Cultures grew single pathogens in 108 cases, and 2 grew multiple pathogens; in 127 cases, no pathogenic organisms were isolated. In all, 41 (37.96%) isolates grew Gram-positive and 67 (62.04%) grew Gram-negative organisms. The most effective antibiotic against Gram-negative bacteria was imipenem (50%) and that against Gram-positive bacteria was vancomycin (70.59%). All isolates were resistant to ampicillin. Conclusion: Sputum culture is a good and simple tool to study the aetiology and complications caused by bacteria in AECOPD. The antibiogram helps in identifying the correct treatment and timely initiation of appropriate antimicrobial therapy, thereby helping reduce mortality and morbidity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.